PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT

PREDICTIVE VALUE OF SEATTLE HEART FAILURE MODEL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT

Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, ang...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1342-A1342
Hauptverfasser: Sinibaldi, Everett, Ramanan, Thammi, Sawant, Abhishek, Bhardwaj, Aishwarya, Hansen, Rosemary, Pham, Michael, Khalil, Charl, Sharma, Ashutosh, Kumar, Abhinav, Iyer, Vijay
Format: Artikel
Sprache:eng
Schlagworte:
Aortic valve
Cardiology
Diuretics
Heart diseases
Heart failure
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Seattle Heart Failure Model (SHFM) is a validated risk assessment tool in heart failure (HF) patients, but its utility for predicting survival in patients undergoing transcatheter aortic valve replacement (TAVR) remains to be evaluated. Use of beta-blockers was 68%, diuretics was 65%, angiotensin converting enzyme inhibitors was 24%, aldosterone receptor blockers was 17%, and potassium-sparing diuretics was 7%.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31883-7